Presentation TCT 2021 Tricuspid Valve Interventions - Adding Quality of Life to Years, from Industry Perspective Presenter: Suzanne Arnold November 05, 2021 REGISTER for free or LOG IN to view this content Structural Heart TCT 2021 Tricuspid Valve Up Next Presentation TCT 2021 Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From Academic Perspective Presenter: William Abraham November 05, 2021 More slides + Presentation TCT 2021 Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From FDA Perspective Presenter: Meir Shinnar November 05, 2021 Presentation TCT 2021 Left Atrial Appendage Interventions – Closing the Key Evidence Gaps to Move the Field Forward, From FDA Perspective Presenter: Kan Fang November 05, 2021 We Recommend Disclosures Nothing to disclose
Presentation TCT 2021 Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From Academic Perspective Presenter: William Abraham November 05, 2021
Presentation TCT 2021 Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From FDA Perspective Presenter: Meir Shinnar November 05, 2021
Presentation TCT 2021 Left Atrial Appendage Interventions – Closing the Key Evidence Gaps to Move the Field Forward, From FDA Perspective Presenter: Kan Fang November 05, 2021